Key Laboratory of Biorheological Science and Technology, Ministry of Education, College of Bioengineering, Chongqing University, Chongqing, China.
Southwest Hospital/Southwest Eye Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
Cell Prolif. 2023 Dec;56(12):e13496. doi: 10.1111/cpr.13496. Epub 2023 May 22.
Coronavirus disease 2019 (COVID-19), a global pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has posed a catastrophic threat to human health worldwide. Human stem cell-derived organoids serve as a promising platform for exploring SARS-CoV-2 infection. Several review articles have summarized the application of human organoids in COVID-19, but the research status and development trend of this field have seldom been systematically and comprehensively studied. In this review, we use bibliometric analysis method to identify the characteristics of organoid-based COVID-19 research. First, an annual trend of publications and citations, the most contributing countries or regions and organizations, co-citation analysis of references and sources and research hotspots are determined. Next, systematical summaries of organoid applications in investigating the pathology of SARS-CoV-2 infection, vaccine development and drug discovery, are provided. Lastly, the current challenges and future considerations of this field are discussed. The present study will provide an objective angle to identify the current trend and give novel insights for directing the future development of human organoid applications in SARS-CoV-2 infection.
新型冠状病毒病(COVID-19)是由严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)引起的全球性大流行疾病,对全球人类健康构成了灾难性威胁。人类干细胞衍生的类器官为探索 SARS-CoV-2 感染提供了一个很有前途的平台。已有几篇综述文章总结了人类类器官在 COVID-19 中的应用,但该领域的研究现状和发展趋势很少被系统和全面地研究。在这篇综述中,我们使用文献计量分析方法来确定基于类器官的 COVID-19 研究的特点。首先,确定出版物和引文的年度趋势、最有贡献的国家或地区和组织、参考文献和来源的共引分析以及研究热点。其次,对类器官在研究 SARS-CoV-2 感染的病理学、疫苗开发和药物发现方面的应用进行了系统总结。最后,讨论了该领域目前的挑战和未来的考虑因素。本研究将提供一个客观的角度来确定当前的趋势,并为指导人类类器官在 SARS-CoV-2 感染中的应用的未来发展提供新的见解。